Daniel Donner

Dr. Daniel Donner is an Adjunct Senior Research Fellow at Monash University and the University of Melbourne. He holds a Senior Research Fellow position at the Baker Heart and Diabetes Institute, where he leads the Translational Cardiology Research Group. His roles include overseeing a team of senior research staff, undergraduate, and postgraduate students, focusing on cardiovascular research and translational medicine.

Dr. Donner earned a Bachelor of Biomedical Science from Griffith University (2008), followed by a Master of Medical Research (2010) and a PhD (2015) in Selective Androgen Receptor Modulation from the same institution. He also holds a Graduate Certificate in Research Management (2012) from Southern Cross University and a Certificate of Leadership from Harvard University (2020).

His research focuses on the impact of biological sex and sex hormones on cardiovascular disease and injury, immune system modulation in cardiac injury (e.g., heart attacks and cardiac arrest), and improving rigor and reproducibility in preclinical cardiology research to enhance translation from bench to bedside. Key areas include myocardial infarction, cardiac arrest, heart failure, and preclinical trials.

In addition to his academic roles, Dr. Donner has secured over $7.5 million in research funding since 2019, including grants from NHMRC and industry partners. He has received prestigious awards such as the ISHR Early Career Investigator Prize (2019), John Funder Early-Mid Career Investigator Award (2022), and the Baker Early-Career Scientist Award (2023). His work aligns with UN Sustainable Development Goals related to health and well-being.

As the leader of the Translational Cardiology Research Group, he directs research activities in preclinical trial design, myocardial infarction models, and cardiac arrest models. His team emphasizes collaborative efforts to advance cardiac health research and clinical applications.